Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCNKS.L Regulatory News (CNKS)

  • There is currently no data for CNKS

Directorate Change

16 Oct 2019 16:11

RNS Number : 1333Q
Cenkos Securities PLC
16 October 2019
 

16 October 2019

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation EU 596/2014 ("MAR").

 

 

Cenkos Securities plc

("Cenkos" or the "Company")

 

Directorate Change

 

The Board of Cenkos is pleased to announce the appointment of Julian Morse, as an Executive Director of the Company. This appointment is subject to Financial Conduct Authority approval and will take effect on the receipt of regulatory consent.

 

Julian is Head of the Cenkos Growth Companies Team and has led that team since 2016. He is one of the founding members of the team having joined Cenkos in 2006. He has over 25 years' experience in the City where he has advised and raised equity on IPO's and secondary fund raisings for a wide range of companies across a broad range of sectors. Previously, Julian was a Director at Beeson Gregory and Evolution Securities.

Commenting on the appointment, Jeff Hewitt Acting Chairman of the Company, said:

"I am delighted that Julian has agreed to join the Board. With Julian's experience and proven success in managing the Growth Companies team he will provide a valuable addition to the Board and will assist in driving the whole business forward."

Additional Information

 

In accordance with the AIM Rules, the following information is required to be disclosed in relation to Julian Morse is set out below. Other than this information, there is no further information required to be disclosed under paragraph (g) of Schedule Two of the AIM Rules.

 

Full Name and age:

Julian Jonathan Morse aged 48

 

Current Directorships/Partnerships:

None

 

Previous Directorships/Partnerships:

Dovemoat LLP - LLP member resigned 17 November 2015

 

Current interest in the Company's share capital:

403,239 Ordinary shares of 1 pence held under his Self-Invested Personal Pension

384,501 Ordinary shares of 1 pence held in accordance with the terms and conditions of Company's Deferred Bonus Scheme

18,842 Ordinary shares of 1 pence shares held in the Company's Share Incentive Plan of which X are subject to forfeiture

 

Options over 185,220 Ordinary shares held under the Compensatory Award Plan Options. These options are at 169.0 pence. These options expire on 22 October 2019.

 

Options over 21,094 Ordinary shares held under the Company's Save As You Earn Plan. These options are at 85.3 pence. These options expire on 30 November 2021.

 

 

 

 

Enquiries:

 

Cenkos Securities plc

Jim Durkin, Chief Executive Officer

 

Tel: 0207 397 8900

SPARK Advisory Partners Limited

Matt Davis, Nominated Adviser

 

Tel: 0203 368 3552

Whitman Howard Limited

Nick Lovering, Broker

 

Tel: 0207 659 1224

Buchanan Communications

David Rydell, PR Adviser

Tel: 0207 466 5066

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOABUBDGRGBBGCL
Date   Source Headline
6th Nov 20179:54 amRNSForm 8.5 (EPT/NON-RI)
2nd Nov 20179:49 amRNSForm 8.5 (EPT/NON-RI)
1st Nov 20179:56 amRNSForm 8.5 (EPT/NON-RI)
30th Oct 201710:52 amRNSHolding(s) in Company
24th Oct 20179:24 amRNSForm 8.5 (EPT/NON-RI)
19th Oct 20177:00 amRNSDirectorate Change
18th Oct 20174:53 pmRNSEBT Share Purchase
16th Oct 20177:00 amRNSBlock Admission Interim Review
13th Oct 20172:09 pmRNSHolding(s) in Company
28th Sep 20174:41 pmRNSDirector/PDMR Shareholding
26th Sep 20177:00 amRNSHalf-year Report
21st Sep 20174:51 pmRNSEBT Share Purchase
19th Sep 20175:36 pmRNSHolding(s) in Company
13th Sep 20174:58 pmRNSDirectorate Change
13th Sep 20172:31 pmRNSHolding(s) in Company
22nd Aug 20176:09 pmRNSEBT Share Purchase
14th Aug 20179:40 amRNSForm 8.5 (EPT/NON-RI)
11th Aug 20179:44 amRNSForm 8.5 (EPT/NON-RI)
9th Aug 201710:39 amRNSForm 8.5 (EPT/NON-RI)
4th Aug 201710:23 amRNSForm 8.5 (EPT/NON-RI)
4th Aug 20177:00 amRNSDirectorate Change
2nd Aug 20174:44 pmRNSHolding(s) in Company
2nd Aug 20177:00 amRNSFurther re Directorate Change
1st Aug 201710:13 amRNSForm 8.5 (EPT/NON-RI)
25th Jul 201710:10 amRNSForm 8.5 (EPT/NON-RI)
24th Jul 201710:09 amRNSForm 8.5 (EPT/NON-RI)
21st Jul 20176:20 pmRNSEBT Share Purchase
21st Jul 20179:51 amRNSForm 8.5 (EPT/NON-RI)
18th Jul 201710:00 amEQSCenkos Securities PLC: Small Cap Advisor of the Year award at the fifth annual Nex Exchange Small Cap Awards 2017
17th Jul 201710:37 amRNSForm 8.5 (EPT/NON-RI)
11th Jul 20177:00 amRNSDirector/PDMR Shareholding
7th Jul 20179:44 amRNSForm 8.5 (EPT/NON-RI)
5th Jul 20177:00 amRNSDirectorate Changes
4th Jul 20179:59 amRNSForm 8.5 (EPT/NON-RI)
27th Jun 20179:54 amRNSForm 8.5 (EPT/NON-RI)
26th Jun 201710:28 amRNSForm 8.5 (EPT/NON-RI)
26th Jun 20177:57 amRNSStatement re Press Speculation
20th Jun 20179:47 amRNSForm 8.5 (EPT/NON-RI)
16th Jun 20172:56 pmRNSEBT Share Purchase
16th Jun 201710:43 amRNSForm 8.5 (EPT/NON-RI)
14th Jun 201710:09 amRNSForm 8.5 (EPT/NON-RI)
2nd Jun 20174:03 pmRNSDirector/PDMR Shareholding
30th May 20175:48 pmRNSEBT Share Purchase
26th May 20179:23 amRNSForm 8.5 (EPT/NON-RI)
23rd May 20175:48 pmRNSEBT Share Purchase Plan
19th May 201710:38 amRNSForm 8.5 (EPT/NON-RI)
17th May 20174:22 pmRNSDirector/PDMR Shareholding
17th May 20172:01 pmRNSResult of AGM
12th May 201710:31 amRNSForm 8.5 (EPT/NON-RI)
12th May 201710:06 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.